Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen

BACKGROUND: Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in at-risk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing seru...

Descripción completa

Detalles Bibliográficos
Autores principales: Claydon, Jennifer, Sur, Amitava, Callejas, Allison, Ladd, Mihoko, Kwan, Eddie, Taylor, Richard, Turvey, Stuart E., Solimano, Alfonso, Lavoie, Pascal M., Marr, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402955/
https://www.ncbi.nlm.nih.gov/pubmed/28437470
http://dx.doi.org/10.1371/journal.pone.0176152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402955/
https://www.ncbi.nlm.nih.gov/pubmed/28437470
http://dx.doi.org/10.1371/journal.pone.0176152

Ejemplares similares